...
rdhl-img

Redhill Biopharma Ltd, Common Stock

RDHL

NAQ

$7.095

-$0.07

(-0.98%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.02K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
3.67
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.34 L
$40.5 H
$7.095

About Redhill Biopharma Ltd, Common Stock

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameRDHLSectorS&P500
1-Week Return-11.82%-3.39%0.2%
1-Month Return2.43%-1.92%2.72%
3-Month Return-30.75%-10.54%7.31%
6-Month Return-27.7%-4.47%10.44%
1-Year Return-76.52%4.06%27.53%
3-Year Return-99.73%0.94%30.88%
5-Year Return-99.88%36.67%89.21%
10-Year Return-99.94%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.29M64.36M85.76M61.80M6.51M[{"date":"2019-12-31","value":7.34,"profit":true},{"date":"2020-12-31","value":75.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.06,"profit":true},{"date":"2023-12-31","value":7.59,"profit":true}]
Cost of Revenue2.26M36.89M49.41M33.34M3.46M[{"date":"2019-12-31","value":4.57,"profit":true},{"date":"2020-12-31","value":74.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.48,"profit":true},{"date":"2023-12-31","value":7,"profit":true}]
Gross Profit4.03M27.47M36.35M28.46M3.05M[{"date":"2019-12-31","value":11.09,"profit":true},{"date":"2020-12-31","value":75.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.3,"profit":true},{"date":"2023-12-31","value":8.4,"profit":true}]
Gross Margin64.09%42.68%42.39%46.06%46.89%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.59,"profit":true},{"date":"2021-12-31","value":66.14,"profit":true},{"date":"2022-12-31","value":71.86,"profit":true},{"date":"2023-12-31","value":73.16,"profit":true}]
Operating Expenses47.23M91.15M117.49M71.31M(9.56M)[{"date":"2019-12-31","value":40.2,"profit":true},{"date":"2020-12-31","value":77.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.69,"profit":true},{"date":"2023-12-31","value":-8.14,"profit":false}]
Operating Income(43.20M)(63.68M)(81.14M)(42.84M)12.63M[{"date":"2019-12-31","value":-342,"profit":false},{"date":"2020-12-31","value":-504.15,"profit":false},{"date":"2021-12-31","value":-642.3,"profit":false},{"date":"2022-12-31","value":-339.17,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense902.00K(25.06M)(33.19M)(70.07M)9.16M[{"date":"2019-12-31","value":9.85,"profit":true},{"date":"2020-12-31","value":-273.55,"profit":false},{"date":"2021-12-31","value":-362.26,"profit":false},{"date":"2022-12-31","value":-764.83,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(42.30M)(76.17M)(97.74M)(71.67M)23.95M[{"date":"2019-12-31","value":-176.62,"profit":false},{"date":"2020-12-31","value":-318.02,"profit":false},{"date":"2021-12-31","value":-408.08,"profit":false},{"date":"2022-12-31","value":-299.22,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes1.33M12.84M16.57M(12.42M)(2.00)[{"date":"2019-12-31","value":8.03,"profit":true},{"date":"2020-12-31","value":77.53,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-74.99,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(43.63M)(89.02M)(114.31M)(59.24M)23.95M[{"date":"2019-12-31","value":-182.17,"profit":false},{"date":"2020-12-31","value":-371.65,"profit":false},{"date":"2021-12-31","value":-477.25,"profit":false},{"date":"2022-12-31","value":-247.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(42.30M)(76.17M)(97.74M)(71.67M)23.92M[{"date":"2019-12-31","value":-176.89,"profit":false},{"date":"2020-12-31","value":-318.5,"profit":false},{"date":"2021-12-31","value":-408.7,"profit":false},{"date":"2022-12-31","value":-299.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(43.63M)(89.02M)(114.31M)(59.24M)23.92M[{"date":"2019-12-31","value":-182.45,"profit":false},{"date":"2020-12-31","value":-372.21,"profit":false},{"date":"2021-12-31","value":-477.97,"profit":false},{"date":"2022-12-31","value":-247.72,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)(1.45)(2.10)(2.10)(0.90)(1.54)[{"date":"2019-12-31","value":-145,"profit":false},{"date":"2020-12-31","value":-210,"profit":false},{"date":"2021-12-31","value":-210,"profit":false},{"date":"2022-12-31","value":-90,"profit":false},{"date":"2023-12-31","value":-154.11,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RDHL
Cash Ratio 0.25
Current Ratio 0.96
Quick Ratio 0.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RDHL
ROA (LTM) -44.88%
ROE (LTM) -1708.61%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RDHL
Debt Ratio Lower is generally better. Negative is bad. 0.90
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.10

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RDHL
Trailing PE NM
Forward PE 1428.57
P/S (TTM) 2.47
P/B 150.31
EV/R 0.66
EV/Ebitda 0.30
PEG NM

FAQs

What is Redhill Biopharma Ltd share price today?

Redhill Biopharma Ltd (RDHL) share price today is $7.095

Can Indians buy Redhill Biopharma Ltd shares?

Yes, Indians can buy shares of Redhill Biopharma Ltd (RDHL) on Vested. To buy Redhill Biopharma Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RDHL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Redhill Biopharma Ltd be purchased?

Yes, you can purchase fractional shares of Redhill Biopharma Ltd (RDHL) via the Vested app. You can start investing in Redhill Biopharma Ltd (RDHL) with a minimum investment of $1.

How to invest in Redhill Biopharma Ltd shares from India?

You can invest in shares of Redhill Biopharma Ltd (RDHL) via Vested in three simple steps:

  • Click on Sign Up or Invest in RDHL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Redhill Biopharma Ltd shares
What is Redhill Biopharma Ltd 52-week high and low stock price?

The 52-week high price of Redhill Biopharma Ltd (RDHL) is $40.5. The 52-week low price of Redhill Biopharma Ltd (RDHL) is $6.34.

What is Redhill Biopharma Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Redhill Biopharma Ltd (RDHL) is

What is Redhill Biopharma Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Redhill Biopharma Ltd (RDHL) is 150.31

What is Redhill Biopharma Ltd dividend yield?

The dividend yield of Redhill Biopharma Ltd (RDHL) is 0.00%

What is the Market Cap of Redhill Biopharma Ltd?

The market capitalization of Redhill Biopharma Ltd (RDHL) is $9.17M

What is Redhill Biopharma Ltd’s stock symbol?

The stock symbol (or ticker) of Redhill Biopharma Ltd is RDHL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top